bullish
Samsung BioLogics' First Trading Day - Blunders in Barron's Argument & Price Prediction
241 Views10 Nov 2016 06:20
As reported by Barron's on Nov 5 ("Samsung BioLogics IPO: Too Expensive"), there are still some skeptical views on BioLogics' IPO valuation....
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 6-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Revisiting Samsung BioLogics at This Interesting Time05 Feb 2017
- Samsung Biologics IPO: Another Way for the Company's Relative Valuation15 Nov 2016
- Recap of Samsung BioLogics' First Trading Day - Foreign Institutions Net Purchased 1M Shares11 Nov 2016
- Samsung BioLogics IPO - Why Investors Are Excited & Concerned01 Nov 2016
- Samsung BioLogics IPO Price Is Set At Highest End (₩136,000) - 3 Points to Consider28 Oct 2016
x